UY28256A1 - Emulsiones de aceite en agua microfludizadas y composiciones de vacunas - Google Patents
Emulsiones de aceite en agua microfludizadas y composiciones de vacunasInfo
- Publication number
- UY28256A1 UY28256A1 UY28256A UY28256A UY28256A1 UY 28256 A1 UY28256 A1 UY 28256A1 UY 28256 A UY28256 A UY 28256A UY 28256 A UY28256 A UY 28256A UY 28256 A1 UY28256 A1 UY 28256A1
- Authority
- UY
- Uruguay
- Prior art keywords
- vaccine compositions
- microfludized
- oil emulsions
- water oil
- emulsions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Abstract
Esta invención proporciona emulsiones submicrométricas de aceite en agua de utilidad como adyuvante de vacuna para potenciar la capacidad inmunógena de antígenos. La presente invención proporciona también composiciones de vacunas que contienen un antígeno combinado con emulsiones de ese tipo de forma intrínseca o extrínseca. La presente invención proporciona también procedimientos para preparar las emulsiones y vacunas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46030103P | 2003-04-04 | 2003-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28256A1 true UY28256A1 (es) | 2004-11-30 |
Family
ID=33131921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28256A UY28256A1 (es) | 2003-04-04 | 2004-04-02 | Emulsiones de aceite en agua microfludizadas y composiciones de vacunas |
Country Status (25)
Country | Link |
---|---|
US (2) | US20040258701A1 (es) |
EP (1) | EP1613346B8 (es) |
JP (1) | JP2006522090A (es) |
KR (1) | KR100720213B1 (es) |
CN (1) | CN1767854B (es) |
AR (1) | AR043803A1 (es) |
AU (1) | AU2004226591B2 (es) |
BR (1) | BRPI0408635B1 (es) |
CA (1) | CA2521051C (es) |
CL (1) | CL2004000691A1 (es) |
CY (1) | CY1113546T1 (es) |
DK (1) | DK1613346T3 (es) |
ES (1) | ES2398235T3 (es) |
HK (1) | HK1086484A1 (es) |
MX (1) | MXPA05010697A (es) |
NO (1) | NO20054376L (es) |
NZ (1) | NZ542576A (es) |
PL (1) | PL1613346T3 (es) |
PT (1) | PT1613346E (es) |
RU (2) | RU2541809C2 (es) |
SI (1) | SI1613346T1 (es) |
TW (1) | TWI353850B (es) |
UY (1) | UY28256A1 (es) |
WO (1) | WO2004087204A2 (es) |
ZA (1) | ZA200507994B (es) |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655252B2 (en) | 1999-04-28 | 2010-02-02 | The Regents Of The University Of Michigan | Antimicrobial nanoemulsion compositions and methods |
US7767216B2 (en) * | 1999-04-28 | 2010-08-03 | The Regents Of The University Of Michigan | Antimicrobial compositions and methods of use |
JP4164361B2 (ja) | 2000-11-07 | 2008-10-15 | イムノワクチン テクノロジーズ インコーポレーテッド | 増強した免疫応答を有するワクチン、およびその調製方法 |
EP2263687B1 (en) * | 2002-12-27 | 2015-03-25 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions containing phospholipid |
US20050208083A1 (en) | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
GB0319500D0 (en) | 2003-08-19 | 2003-09-17 | Resolution Chemicals Ltd | Particle-size reduction apparatus,and use thereof |
JP5393978B2 (ja) * | 2004-04-05 | 2014-01-22 | ゾエティス・ピー・エルエルシー | マイクロ流動化された水中油型乳剤及びワクチン組成物 |
EP1802287A2 (en) * | 2004-09-27 | 2007-07-04 | Sigmoid Biotechnologies Limited | Minicapsule formulations |
FR2878746B1 (fr) | 2004-12-02 | 2007-02-23 | Vetoquinol Sa Sa | Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins |
GB0427568D0 (en) | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
CA2604392A1 (en) * | 2005-04-11 | 2006-10-19 | Nanobio Corporation | Quaternary ammonium halides for treatment of infectious conditions |
CN101384247B (zh) * | 2005-07-18 | 2013-05-22 | 麻萨诸塞州洛厄尔大学 | 制备与使用纳米乳剂的组合物和方法 |
WO2008051186A2 (en) * | 2005-08-09 | 2008-05-02 | Nanobio Corporation | Nanoemulsion containing compositions having ant i -inflammatory activity |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
EP2377550B1 (en) * | 2006-09-11 | 2015-03-04 | Zoetis P LLC | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
CA2683407C (en) | 2007-04-04 | 2016-09-20 | Sigmoid Pharma Limited | Pharmaceutical cyclosporin compositions |
US8747872B2 (en) | 2007-05-02 | 2014-06-10 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
CN101827613A (zh) | 2007-09-27 | 2010-09-08 | 免疫疫苗技术有限公司 | 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用 |
DK2224951T3 (da) * | 2007-12-21 | 2020-01-06 | Zoetis Services Llc | Varmebehandlede bakteriner og emulsionsvacciner, der er fremstillet af sådanne varmebehandlede bakteriner |
US8444989B1 (en) * | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
CA2723918C (en) | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
ES2728949T3 (es) | 2008-06-27 | 2019-10-29 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
WO2010133609A2 (en) | 2009-05-18 | 2010-11-25 | Sigmoid Pharma Limited | Composition comprising oil drops |
CN102573802A (zh) * | 2009-08-12 | 2012-07-11 | 希格默伊德药业有限公司 | 包含聚合物基质和油相的免疫调节组合物 |
EP3141246A1 (en) | 2009-08-31 | 2017-03-15 | Dr. Reddy's Laboratories Ltd. | Topical formulations comprising a steroid |
DE102009056883B4 (de) * | 2009-12-03 | 2012-08-16 | Novartis Ag | Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben |
BR112012013426B8 (pt) * | 2009-12-03 | 2021-05-25 | Novartis Ag | métodos para a fabricação de uma emulsão de óleo-em-água, para preparar uma composição de vacina e para preparar um kit de vacina |
DE102009056871A1 (de) | 2009-12-03 | 2011-06-22 | Novartis AG, 4056 | Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben |
CL2012001399A1 (es) | 2009-12-03 | 2013-03-08 | Novartis Ag | Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion. |
FI2638895T3 (fi) * | 2009-12-03 | 2024-06-20 | Seqirus Uk Ltd | Ainesosien kierrätys emulsioiden homogenisoinnin aikana |
EP2601933B1 (en) | 2009-12-03 | 2015-10-07 | Novartis AG | Hydrophilic filtration during manufacture of vaccine adjuvants |
DE102009056884B4 (de) | 2009-12-03 | 2021-03-18 | Novartis Ag | Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben |
FR2957803B1 (fr) * | 2010-03-24 | 2012-06-01 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Diluants adjuvants de vaccins vivants pour maladies porcines |
CN101829323A (zh) * | 2010-04-28 | 2010-09-15 | 洛阳普莱柯生物工程有限公司 | 一种禽用油乳剂疫苗及其制备方法 |
GB201009673D0 (en) * | 2010-06-10 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel process |
CN101926994B (zh) * | 2010-08-19 | 2012-10-10 | 中国医学科学院医学生物学研究所 | 一种鳖甲免疫佐剂及含有该佐剂的流感疫苗 |
CN101926995B (zh) * | 2010-08-19 | 2013-05-29 | 中国医学科学院医学生物学研究所 | 一种天冬免疫佐剂及含有该佐剂的流感疫苗 |
CN101978948A (zh) * | 2010-11-02 | 2011-02-23 | 扬州威克生物工程有限公司 | 兽用油乳剂灭活疫苗的低温乳化工艺方法 |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
US10206996B2 (en) | 2011-08-22 | 2019-02-19 | Nanobio Corporation | Herpes simplex virus nanoemulsion vaccine |
EP2763698B1 (en) | 2011-10-06 | 2020-12-02 | ImmunoVaccine Technologies Inc. | Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CA3216609C (en) | 2012-08-14 | 2024-05-14 | 10X Genomics, Inc. | Microcapsule compositions and methods |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9567631B2 (en) | 2012-12-14 | 2017-02-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
EP2938317A1 (fr) * | 2012-12-27 | 2015-11-04 | Jean-Claude Epiphani | Procede de fabrication d'une emulsion aqueuse d'une substance active huileuse pour application cosmetique, alimentaire ou pharmaceutique |
CA2900543C (en) | 2013-02-08 | 2023-01-31 | 10X Genomics, Inc. | Partitioning and processing of analytes and other species |
US10395758B2 (en) | 2013-08-30 | 2019-08-27 | 10X Genomics, Inc. | Sequencing methods |
AU2014321369B2 (en) | 2013-09-19 | 2020-04-16 | Zoetis Services Llc | Oil-based adjuvants |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
US9824068B2 (en) | 2013-12-16 | 2017-11-21 | 10X Genomics, Inc. | Methods and apparatus for sorting data |
US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
WO2015157567A1 (en) | 2014-04-10 | 2015-10-15 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
EP3161700B1 (en) | 2014-06-26 | 2023-03-29 | 10X Genomics, Inc. | Processes and systems for nucleic acid sequence assembly |
EP4053292A1 (en) | 2014-06-26 | 2022-09-07 | 10X Genomics, Inc. | Methods of analyzing nucleic acids from individual cells or cell populations |
PL3166634T3 (pl) * | 2014-07-11 | 2021-12-27 | Zoetis Services Llc | Nowe kompozycje szczepionek przeciwko wirusowi biegunki epidemicznej świń |
US10143738B2 (en) * | 2014-09-12 | 2018-12-04 | Intervet Inc. | Vaccine for use in protecting a pig against porcine epidemic diarrhea virus |
CN114807307A (zh) | 2014-10-29 | 2022-07-29 | 10X 基因组学有限公司 | 用于靶核酸测序的方法和组合物 |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
BR112017009510A2 (pt) | 2014-11-07 | 2017-12-19 | Sigmoid Pharma Ltd | composições compreendendo ciclosporina |
BR112017014902A2 (pt) | 2015-01-12 | 2018-03-13 | 10X Genomics Inc | processos e sistemas para a preparação de bibliotecas de sequenciamento de ácido nucleico e bibliotecas preparadas usando os mesmos |
CA2968417A1 (en) | 2015-01-13 | 2016-07-21 | 10X Genomics, Inc. | Systems and methods for visualizing structural variation and phasing information |
WO2016115456A1 (en) | 2015-01-16 | 2016-07-21 | Zoetis Services Llc | Foot-and-mouth disease vaccine |
EP3256606B1 (en) | 2015-02-09 | 2019-05-22 | 10X Genomics, Inc. | Systems and methods for determining structural variation |
US11274343B2 (en) | 2015-02-24 | 2022-03-15 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequence coverage |
WO2016137973A1 (en) | 2015-02-24 | 2016-09-01 | 10X Genomics Inc | Partition processing methods and systems |
WO2016138421A1 (en) | 2015-02-27 | 2016-09-01 | Iowa State University Research Foundation, Inc. | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom |
CN115369161A (zh) | 2015-12-04 | 2022-11-22 | 10X 基因组学有限公司 | 用于核酸分析的方法和组合物 |
EP3414341A4 (en) | 2016-02-11 | 2019-10-09 | 10X Genomics, Inc. | SYSTEMS, METHODS, AND MEDIA FOR ASSEMBLING NOVO OF GENOME SEQUENCE DATA OVERALL |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
JP6253210B1 (ja) * | 2016-08-17 | 2017-12-27 | 一般財団法人日本生物科学研究所 | 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット |
JP2019535829A (ja) | 2016-11-21 | 2019-12-12 | エイリオン セラピューティクス, インコーポレイテッド | 大型薬剤の経皮送達 |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
EP4029939B1 (en) | 2017-01-30 | 2023-06-28 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
WO2018213774A1 (en) | 2017-05-19 | 2018-11-22 | 10X Genomics, Inc. | Systems and methods for analyzing datasets |
US20180340169A1 (en) | 2017-05-26 | 2018-11-29 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
SG11201901822QA (en) | 2017-05-26 | 2019-03-28 | 10X Genomics Inc | Single cell analysis of transposase accessible chromatin |
CN111051523B (zh) | 2017-11-15 | 2024-03-19 | 10X基因组学有限公司 | 功能化凝胶珠 |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
EP3727443A1 (en) * | 2017-12-20 | 2020-10-28 | Zoetis Services LLC | Vaccines against hendra and nipah virus infection |
CN108159414B (zh) * | 2018-01-15 | 2021-07-27 | 四川诺顺科技有限公司 | 动物疫苗用油包水佐剂及其制备方法和用途 |
SG11202009889VA (en) | 2018-04-06 | 2020-11-27 | 10X Genomics Inc | Systems and methods for quality control in single cell processing |
CN108721614A (zh) * | 2018-06-12 | 2018-11-02 | 福建省农业科学院畜牧兽医研究所 | 兔葡萄球菌病、波氏杆菌病二联组织灭活疫苗及制备方法 |
CN110665002B (zh) * | 2019-10-29 | 2023-01-24 | 信阳市动物疫病预防控制中心 | 一种用于防治牛病毒性腹泻的抗体制剂及其制备方法 |
US11786592B2 (en) * | 2021-05-19 | 2023-10-17 | The University Of Hong Kong | Compositions of cardiolipin adjuvants and methods of use thereof |
US20230109193A1 (en) * | 2021-10-02 | 2023-04-06 | Massachusetts Institute Of Technology | Synergistic Combination of Alum and Non-Liposome, Non-Micelle Particle Vaccine Adjuvants |
CN114569715A (zh) * | 2022-05-07 | 2022-06-03 | 中义(北京)健康研究院 | 疫苗组合物、疫苗佐剂及其制备方法和制备系统 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
US4908154A (en) * | 1981-04-17 | 1990-03-13 | Biotechnology Development Corporation | Method of forming a microemulsion |
US4505900A (en) * | 1982-05-26 | 1985-03-19 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4606918A (en) * | 1983-08-22 | 1986-08-19 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
US4772466A (en) * | 1983-08-22 | 1988-09-20 | Syntex (U.S.A.) Inc. | Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants |
CA1280739C (en) | 1985-09-19 | 1991-02-26 | Tatsuo Kinoshita | Oil-in-water emulsion and use thereof as metal processing oil or the like |
US4803070A (en) * | 1986-04-15 | 1989-02-07 | Ribi Immunochem Research Inc. | Immunological emulsion adjuvants for polysaccharide vaccines |
US4806350A (en) | 1986-04-18 | 1989-02-21 | Norden Laboratories, Inc. | Vaccine formulation |
US5084269A (en) * | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
US5376369A (en) * | 1987-11-03 | 1994-12-27 | Syntex (U.S.A.) Inc. | Vaccine adjuvant |
AU626271B2 (en) * | 1987-11-03 | 1992-07-30 | Syntex (U.S.A.) Inc. | Vaccine adjuvant |
JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
US5585103A (en) * | 1991-07-25 | 1996-12-17 | Idec Pharmaceutical Corporation | Induction of cytotoxic T-lymphocyte responses |
AU675930B2 (en) | 1992-02-18 | 1997-02-27 | Pharmos Corp. | Dry compositions for preparing submicron emulsions |
WO1993024147A1 (en) * | 1992-05-29 | 1993-12-09 | Smithkline Beecham Corporation | Lecithin adjuvanted modified live virus vaccines |
RU2058154C1 (ru) * | 1992-12-21 | 1996-04-20 | Всероссийский научно-исследовательский институт защиты животных | Адъювант |
JPH0731413A (ja) | 1993-07-14 | 1995-02-03 | Ajinomoto Co Inc | 広域温度安定性乳化組成物 |
EP0640348A1 (en) * | 1993-07-26 | 1995-03-01 | Akzo Nobel N.V. | Oil-based and water-based adjuvant mixture |
US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
AU5543294A (en) * | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
FR2733151B1 (fr) * | 1995-04-20 | 1997-05-23 | Seppic Sa | Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US5690942A (en) * | 1995-06-02 | 1997-11-25 | American Home Products Corporation | Adjuvants for viral vaccines |
US5718904A (en) * | 1995-06-02 | 1998-02-17 | American Home Products Corporation | Adjuvants for viral vaccines |
US6114319A (en) | 1997-05-14 | 2000-09-05 | Senju Pharmaceutical Co., Ltd. | Compositions containing difluprednate |
SE9702776D0 (sv) | 1997-07-22 | 1997-07-22 | Pharmacia & Upjohn Ab | Method of preparing pharmaceutical compositions |
US6682745B1 (en) | 1998-07-28 | 2004-01-27 | Christiaan Antonius Arnoldus Jacobs | Use of bacterium for manufacture of a vaccine |
JP4426091B2 (ja) | 1997-09-05 | 2010-03-03 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | サポニンを含有する水中油型エマルション |
GB9718901D0 (en) * | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
US6086901A (en) * | 1997-12-16 | 2000-07-11 | Chiron Corporation | Use of microparticles combined with submicron oil-in-water emulsions |
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
JP2002193790A (ja) | 2000-12-27 | 2002-07-10 | Lion Corp | 水難溶性薬剤含有水中油型エマルジョン及びその製造方法 |
-
2004
- 2004-03-22 CN CN2004800086187A patent/CN1767854B/zh not_active Expired - Lifetime
- 2004-03-22 NZ NZ542576A patent/NZ542576A/en not_active IP Right Cessation
- 2004-03-22 MX MXPA05010697A patent/MXPA05010697A/es active IP Right Grant
- 2004-03-22 AU AU2004226591A patent/AU2004226591B2/en not_active Expired
- 2004-03-22 RU RU2009113834/15A patent/RU2541809C2/ru active
- 2004-03-22 DK DK04722345.8T patent/DK1613346T3/da active
- 2004-03-22 RU RU2005130646/13A patent/RU2005130646A/ru unknown
- 2004-03-22 BR BRPI0408635-0A patent/BRPI0408635B1/pt active IP Right Grant
- 2004-03-22 CA CA2521051A patent/CA2521051C/en not_active Expired - Lifetime
- 2004-03-22 KR KR1020057018729A patent/KR100720213B1/ko active IP Right Grant
- 2004-03-22 PT PT47223458T patent/PT1613346E/pt unknown
- 2004-03-22 EP EP04722345A patent/EP1613346B8/en not_active Revoked
- 2004-03-22 JP JP2006506403A patent/JP2006522090A/ja active Pending
- 2004-03-22 PL PL04722345T patent/PL1613346T3/pl unknown
- 2004-03-22 SI SI200431984T patent/SI1613346T1/sl unknown
- 2004-03-22 ES ES04722345T patent/ES2398235T3/es not_active Expired - Lifetime
- 2004-03-22 WO PCT/IB2004/000937 patent/WO2004087204A2/en active Application Filing
- 2004-03-31 AR ARP040101078A patent/AR043803A1/es not_active Application Discontinuation
- 2004-03-31 CL CL200400691A patent/CL2004000691A1/es unknown
- 2004-04-02 UY UY28256A patent/UY28256A1/es not_active Application Discontinuation
- 2004-04-02 TW TW093109274A patent/TWI353850B/zh not_active IP Right Cessation
- 2004-04-05 US US10/818,433 patent/US20040258701A1/en not_active Abandoned
-
2005
- 2005-09-21 NO NO20054376A patent/NO20054376L/no not_active Application Discontinuation
- 2005-10-03 ZA ZA200507994A patent/ZA200507994B/en unknown
-
2006
- 2006-06-07 HK HK06106499.7A patent/HK1086484A1/xx not_active IP Right Cessation
-
2009
- 2009-12-31 US US12/650,715 patent/US8771727B2/en not_active Expired - Lifetime
-
2013
- 2013-01-11 CY CY20131100034T patent/CY1113546T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28256A1 (es) | Emulsiones de aceite en agua microfludizadas y composiciones de vacunas | |
UY28840A1 (es) | Emulsiones de aceite en agua microfluidizadas y composiciones de las vacunas | |
AR054251A1 (es) | Vacuna de toxoide de c. perfringens alfa | |
CR11122A (es) | Vacuna de influenza de emulsion de aceite en agua | |
CY1117874T1 (el) | Χρηση ενος ιου γριπης και ενος ανοσοενισχυτικου γαλακτωματος ελαιου-σε-νερο για την προκλιση αποκρισης των cd4 τ-κυτταρων και/ή βελτιωμενη αποκριση των β-κυτταρων μνημης | |
NO20023829D0 (no) | Proteosom influensavaksine | |
BRPI0619795B8 (pt) | composição imunogênica, composição adjuvante, e, uso de uma composição imunogênica e um adjuvante | |
BRPI0812856A2 (pt) | Composições de vacina de emulsão que compreendem antígeno e adjuvante na fase aquosa. | |
DE60039198D1 (de) | Adjuvanszusammensetzungen zur Erhöhung der Immunantwort bezüglich Polynukleotid-basierenden Impfstoffen | |
CR10726A (es) | Vacuna que comprende un adyuvante de emulsion de aceite en agua | |
AR025750A1 (es) | Vacunas | |
CR11139A (es) | Anticuerpos anti-notch1 nrr y sus metodos de uso | |
AR052498A1 (es) | Vacuna | |
CR8257A (es) | Construcciones de union y metodos para uso de ellas | |
GT201100145A (es) | Vacuna recombinante para influenza aviar y sus usos | |
ATE511855T1 (de) | Adjuvansformulierung zur scheimhaut-applikation | |
CU23759A3 (es) | Composiciones inmunogénicas | |
CL2019000019A1 (es) | Anticuerpos con baja inmunogenicidad y uso de los mismos | |
EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
MX2009005381A (es) | Vacuna para leishmania canina. | |
UY32930A (es) | Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas | |
DE60036705D1 (de) | Adjuvanskombinationen zur immunisierung und vakzine | |
CY1113746T1 (el) | Εμβολιο που περιλαμβανει ανοσοενισχυτικο γαλακτωμα ελαιου σε υδωρ | |
TH72570B (th) | อิมัลชันของน้ำมันในน้ำชนิดผ่านการไมโครฟลูอิดไดซ์ และองค์ประกอบของวัคซีน | |
AR020852A1 (es) | Antigenos de vacuna de leptospira para la prevencion de leptospirosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150521 |